Intravenous Injection of miR-34a Inhibitor Alleviates Diabetes Mellitus-Induced Vascular Endothelial Dysfunction by Targeting NOTCH1.

MLA

Zhao, Di, et al. “Intravenous Injection of MiR-34a Inhibitor Alleviates Diabetes Mellitus-Induced Vascular Endothelial Dysfunction by Targeting NOTCH1.” Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [and] German Diabetes Association, vol. 127, no. 4, Apr. 2019, pp. 255–62. EBSCOhost, https://doi.org/10.1055/s-0043-125324.

APA

Zhao, D., Wang, N.-S., Chen, F., Li, Z.-B., Li, X.-T., & Zhu, X.-X. (2019). Intravenous Injection of miR-34a Inhibitor Alleviates Diabetes Mellitus-Induced Vascular Endothelial Dysfunction by Targeting NOTCH1. Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [and] German Diabetes Association, 127(4), 255–262. https://doi.org/10.1055/s-0043-125324

Chicago

Zhao, Di, Na-Sui Wang, Fu Chen, Zheng-Bing Li, Xi-Tao Li, and Xu-Xin Zhu. 2019. “Intravenous Injection of MiR-34a Inhibitor Alleviates Diabetes Mellitus-Induced Vascular Endothelial Dysfunction by Targeting NOTCH1.” Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [and] German Diabetes Association 127 (4): 255–62. doi:10.1055/s-0043-125324.